Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease

被引:28
|
作者
Hwang, Jin Ho [1 ]
Park, Hayne Cho [1 ,2 ]
Jeong, Jong Cheol [1 ]
Baek, Seon Ha [1 ]
Han, Mi Yeun [1 ]
Bang, Kitae [3 ]
Cho, Jeong Yeon [4 ]
Yu, Suk Hee [5 ]
Yang, Jaeseok [6 ]
Oh, Kook-Hwan [1 ]
Hwang, Young-Hwan [2 ,7 ]
Ahn, Curie [1 ,2 ,6 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak No, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Res Ctr Rare Dis, Seoul 110744, South Korea
[3] Daejeon Eulji Univ Hosp, Dept Internal Med, Taejon, South Korea
[4] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
[5] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul 110744, South Korea
[7] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea
来源
BMC NEPHROLOGY | 2013年 / 14卷
关键词
Polycystic kidney disease; Chronic renal failure; Glomerular filtration rate; Pyuria; Urinary tract infection; CYST FORMATION; PROGRESSION; ADPKD; PKD1; MICE; INACTIVATION; CYSTOGENESIS; PATHOGENESIS; PREVALENCE; DIAGNOSIS;
D O I
10.1186/1471-2369-14-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary tract infection (UTI) occurs in 30%-50% of individuals with autosomal dominant polycystic kidney disease (ADPKD). However, the clinical relevance of asymptomatic pyuria in ADPKD patients remains unknown. Methods: We retrospectively reviewed medical records of 256 ADPKD patients who registered to the ADPKD clinic at Seoul National University Hospital from Aug 1999 to Aug 2010. We defined the asymptomatic pyuria as more than 5-9 white blood cells in high-power field with no related symptoms or signs of overt UTI. Patients were categorized into 2 groups depending on its duration and frequency: Group A included non-pyuria and transient pyuria patients; Group B included recurrent and persistent pyuria patients. The association between asymptomatic pyuria and both the development of overt UTI and the deterioration of renal function were examined. Results: With a mean follow-up duration of 65.3 months, 176 (68.8%) out of 256 patients experienced 681 episodes of asymptomatic pyuria and 50 episodes of UTI. The annual incidence of asymptomatic pyuria was 0.492 episodes/patient/year. The patients in group B showed female predominance (58.5% vs. 42.0%, P=0.01) and experienced an upper UTI more frequently (hazard ratio: 4.612, 95% confidence interval: 1.735-12.258; P=0.002, adjusted for gender and hypertension). The annual change in estimated glomerular filtration rate (Delta eGFR) was significantly larger in magnitude in group B than in group A (-2.7 +/- 4.56 vs. -1.17 +/- 5.8, respectively; P=0.01). Age and Group B found to be the independent variables for Delta eGFR and developing end-stage renal disease (16.0% vs. 4.3%, respectively; P=0.001). Conclusions: Chronic asymptomatic pyuria may increase the risk of developing overt UTI and may contribute to declining renal function in ADPKD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] FACTORS RELATING TO RENAL FUNCTIONAL DETERIORATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD)
    GABOW, PA
    JOHNSON, AM
    KAEHNY, WD
    CHAPMAN, AB
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 248 - 248
  • [32] Renal disease progression in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Shigeo Horie
    Satoru Muto
    Toshio Mochizuki
    Saori Nishio
    Kikuo Nutahara
    Clinical and Experimental Nephrology, 2012, 16 : 622 - 628
  • [33] Kidney volume and function in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Kikuo Nutahara
    Takatsugu Okegawa
    Toshihide Shishido
    Mitsuhiro Tanbo
    Kuninori Kobayasi
    Toshiaki Nitadori
    Clinical and Experimental Nephrology, 2014, 18 : 157 - 165
  • [34] Kidney volume and function in autosomal dominant polycystic kidney disease
    Higashihara, Eiji
    Nutahara, Kikuo
    Okegawa, Takatsugu
    Shishido, Toshihide
    Tanbo, Mitsuhiro
    Kobayasi, Kuninori
    Nitadori, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (01) : 157 - 165
  • [35] Pyuria, urinary tract infection and renal outcome in patients with chronic kidney disease stage 3-5
    Kuo, I-Ching
    Lee, Jia-Jung
    Hwang, Daw-Yang
    Lim, Lee-Moay
    Lin, Hugo You-Hsien
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    Hung, Chi-Chih
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease
    Fassett, Robert G.
    Coombes, Jeff S.
    Packham, David
    Fairley, Kenneth F.
    Kincaid-Smith, Priscilla
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44 (01): : 56 - 61
  • [37] URINARY BIOMARKERS IN THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Santos, Ana Carolina
    Novais, Carla
    Matos, Andreia
    Bicho, Manuel
    Almeida, Edgar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I14 - I14
  • [38] The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease
    Elcioglu, Omer Celal
    Yatci, Beyza
    Ozturk, Burak Baris
    Mirioglu, Safak
    Gursu, Meltem
    Kazancioglu, Rumeyza
    BMC NEPHROLOGY, 2025, 26 (01)
  • [39] Urinary Findings and Biomarkers in Autosomal Dominant Polycystic Kidney Disease
    Kocyigit, Ismail
    Eroglu, Eray
    Ecder, Tevfik
    TURKISH JOURNAL OF NEPHROLOGY, 2020, 29 (01): : 66 - 76
  • [40] Exploring urinary biomarkers in autosomal dominant polycystic kidney disease
    Kawano, Haruna
    Muto, Satoru
    Ohmoto, Yasukazu
    Iwata, Fusako
    Fujiki, Hiroyuki
    Mori, Toyoki
    Yan, Lu
    Horie, Shigeo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (05) : 968 - 973